- Research works
- 9 ▼ 69% vs 2018-21
- Citations
- 234 26.3 per fractional work
- Top-10% rate
- 1.1% all institutions 10.0%
- Open access
- 52% world 40%
- International
- 61% world 18%
Not ranked overall: Albumedix (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Albumedix (United Kingdom) work in?
In all years, 43% of research at Albumedix (United Kingdom) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (32%), Chemistry (7%). It does 1.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 8 fields, with their numbers
- Health Sciences443.0%
- Medicine443.0%
- Life Sciences335.8%
- Physical Sciences217.5%
- Chemistry16.8%
- Engineering16.3%
- Materials Science03.6%
- Environmental Science00.8%
- Social Sciences03.7%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Albumedix (United Kingdom)?
Ranked on the quality score, Jason Cameron lead among researchers whose main affiliation is Albumedix (United Kingdom).
- 1
Jason Cameron
United Kingdom · #1,279,592 worldwide 1.4k citations · 22 works
Which research topics does Albumedix (United Kingdom) publish most on?
By volume in 2022-now: Rheumatoid Arthritis Research and Therapies, CAR-T cell therapy research, Skin and Cellular Biology Research and Transgenic Plants and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 2 CAR-T cell therapy research Oncology 0 works
- 3 Skin and Cellular Biology Research Cell Biology 0 works
- 4 Transgenic Plants and Applications Biotechnology 0 works
- 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 6 Bone health and treatments Oncology 0 works
- 7 RNA Research and Splicing Molecular Biology 0 works
- 8 RNA modifications and cancer Molecular Biology 0 works
- 9 HER2/EGFR in Cancer Research Oncology 0 works
- 10 Cell Adhesion Molecules Research Immunology and Allergy 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Albumedix (United Kingdom)'s research output changed?
Output in 2022-2025 was 69% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nottingham
- University of Nottingham
- Nottingham Trent University
- Nottingham University Hospitals NHS Trust
- British Geological Survey
- Nottinghamshire Healthcare NHS Foundation Trust
- Quotient Clinical (United Kingdom)
- Institute of Mental Health
- Luxfer Group (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Albumedix (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.